Literature DB >> 11401116

Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic failure heart failure.

F Scapellato1, P L Temporelli, E Eleuteri, U Corrà, A Imparato, P Giannuzzi.   

Abstract

OBJECTIVES: This study was undertaken to explore further the relationship between Doppler-derived parameters of pulmonary flow and pulmonary vascular resistance (PVR) and to determine whether PVR could be accurately estimated noninvasively from Doppler flow velocity measurements in patients with chronic heart failure.
BACKGROUND: The assessment of PVR is of great importance in the management of patients with heart failure. However, because of the inconclusive and conflicting data available, Doppler estimation of PVR is still considered unreliable.
METHODS: Simultaneous Doppler echocardiographic examination and right heart catheterization were performed in 63 consecutive sinus rhythm heart failure patients with severe left ventricular systolic dysfunction. Hemodynamic PVR was calculated with the standard formula. The following Doppler variables on pulmonary flow and tricuspid regurgitation velocity curve were correlated with PVR: maximal systolic flow velocity, pre-ejection period (PEP), acceleration time (AcT), ejection time, total systolic time (TT), velocity time integral, and right atrium-ventricular gradient.
RESULTS: At univariate analysis, all variables except maximal systolic flow velocity and velocity time integral showed a significant, although weak, correlation with PVR. The best correlation found was between AcT and PVR (r = -0.68). By regression analysis, only PEP, AcT and TT entered into the final equation, with a cumulative r = 0.87. When the function (PEP/AcT)/TT was correlated with PVR, the correlation coefficient further improved to 0.96. Of note, this function prospectively predicted PVR (r = 0.94) after effective unloading manipulations.
CONCLUSIONS: The analysis of Doppler-derived pulmonary systolic flow is a reliable and accurate tool for estimating and monitoring PVR in patients with chronic heart failure due to left ventricular systolic dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11401116     DOI: 10.1016/s0735-1097(01)01271-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  A new method to estimate pulmonary vascular resistance using diastolic pulmonary artery-right ventricular pressure gradients derived from continuous-wave Doppler velocity measurements of pulmonary regurgitation.

Authors:  Sanae Kaga; Taisei Mikami; Michito Murayama; Kazunori Okada; Nobuo Masauzi; Masahiro Nakabachi; Hisao Nishino; Shinobu Yokoyama; Mutsumi Nishida; Taichi Hayashi; Daisuke Murai; Hiroyuki Iwano; Mamoru Sakakibara; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-30       Impact factor: 2.357

2.  Doppler flow patterns in the right ventricle-to-pulmonary artery shunt and neo-aorta in infants with single right ventricle anomalies: impact on outcome after initial staged palliations.

Authors:  Peter C Frommelt; Eric Gerstenberger; Jeanne Baffa; William L Border; Tim J Bradley; Steven Colan; Jessica Gorentz; Haleh Heydarian; J Blaine John; Wyman W Lai; Jami Levine; Jimmy C Lu; Rachel T McCandless; Stephen Miller; Arni Nutting; Richard G Ohye; Gail D Pearson; Pierre C Wong; Meryl S Cohen
Journal:  J Am Soc Echocardiogr       Date:  2013-03-26       Impact factor: 5.251

3.  4D magnetic resonance flow imaging for estimating pulmonary vascular resistance in pulmonary hypertension.

Authors:  Vitaly O Kheyfets; Michal Schafer; Chris A Podgorski; Joyce D Schroeder; James Browning; Jean Hertzberg; J Kern Buckner; Kendal S Hunter; Robin Shandas; Brett E Fenster
Journal:  J Magn Reson Imaging       Date:  2016-05-13       Impact factor: 4.813

4.  Accuracy of Doppler-derived estimation of pulmonary vascular resistance in congenital heart disease: an index of operability.

Authors:  Gholam Hossein Ajami; Sirous Cheriki; Hamid Amoozgar; Mohammad Borzouee; Manoucher Soltani
Journal:  Pediatr Cardiol       Date:  2011-07-22       Impact factor: 1.655

5.  Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension.

Authors:  Vincent Roule; Fabien Labombarda; Arnaud Pellissier; Rémi Sabatier; Thérèse Lognoné; Sophie Gomes; Emmanuel Bergot; Paul Milliez; Gilles Grollier; Eric Saloux
Journal:  Cardiovasc Ultrasound       Date:  2010-06-07       Impact factor: 2.062

6.  A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model.

Authors:  Juha W Koskenvuo; Rachel Mirsky; Yan Zhang; Franca S Angeli; Sarah Jahn; Tero-Pekka Alastalo; Nelson B Schiller; Andrew J Boyle; Kanu Chatterjee; Teresa De Marco; Yerem Yeghiazarians
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-07       Impact factor: 2.357

Review 7.  Heart failure: hemodynamic assessment using echocardiography.

Authors:  James N Kirkpatrick; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2008-05       Impact factor: 2.931

8.  Normal values of the pulmonary artery acceleration time (PAAT) and the right ventricular ejection time (RVET) in children and adolescents and the impact of the PAAT/RVET-index in the assessment of pulmonary hypertension.

Authors:  Sheeraz Habash; Kai Thorsten Laser; Julia Moosmann; Roland Reif; Werner Adler; Martin Glöckler; Deniz Kececioglu; Sven Dittrich
Journal:  Int J Cardiovasc Imaging       Date:  2019-01-28       Impact factor: 2.357

9.  A simple echocardiographic method to estimate pulmonary vascular resistance.

Authors:  Alexander R Opotowsky; Mathieu Clair; Jonathan Afilalo; Michael J Landzberg; Aaron B Waxman; Lilamarie Moko; Bradley A Maron; Anjali Vaidya; Paul R Forfia
Journal:  Am J Cardiol       Date:  2013-06-01       Impact factor: 2.778

Review 10.  Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Barry A Borlaug; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-05       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.